Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,340 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07200908RecruitingPhase 3
Comparing brelovitug and bulevirtide for hepatitis delta
This trial tests a new drug, brelovitug, against an existing one, bulevirtide, for people with chronic hepatitis delta. It aims to find a better treatment to lower the virus and protect the liver.
GrazAges 18–99 - NCT07201402RecruitingPhase 2
A long-term study of a shoulder blade contraceptive implant
This trial tests a new way to place a contraceptive implant (a small rod that prevents pregnancy) into the shoulder blade area instead of the arm. It might be a good option if you want long-term birth control and are healthy.
Aurora, ColoradoAges 18–45 - NCT07202247RecruitingPhase 2
Improving heart health in prostate cancer patients on hormone therapy
This study tests whether combining a time-restricted eating plan, a heart-healthy diet, and a weight-loss medication (GLP-1 receptor agonist) can help improve heart health and weight in men with prostate cancer who are receiving hormone therapy. It aims to reduce the risk of heart problems caused by hormone treatment.
Duarte, CaliforniaAges 30–79 - NCT07203001RecruitingPhase 2
MAS825 for Still's disease in children and adults
This trial tests a new drug called MAS825 for people with Still's disease that is still active despite other treatments. It aims to see if the drug can reduce symptoms like fever, rash, joint pain, or a serious complication called macrophage activation syndrome.
Cincinnati, OhioAges 1–100 - NCT07203131Recruiting
NAD+ metabolism and kidney risk in intensive care
This trial tests whether changes in NAD+ (a natural molecule in your cells) affect kidney health during intensive care. It aims to predict and prevent acute kidney injury in patients at high risk.
TrappesAges 18 years+ - NCT07203313Recruiting
Digital app for PE teachers and students in grades 3-5
This study tests a digital app called Pocket PE to help teachers lead physical education activities. It aims to improve skills training for teachers and make PE more fun and effective for students in grades 3 to 5.
Eugene, OregonAges 7 years+ - NCT07203833Recruiting
Vasorin test for shock diagnosis and outlook
This study looks at a protein called vasorin in the blood to see if it can help diagnose and predict outcomes in people with severe shock in the ICU. It compares patients with septic shock (caused by infection) to those with shock from other causes.
AmiensAges 18 years+ - NCT07204418RecruitingPhase 1
Study of KarXT effects based on CYP2D6 metabolism types
This study tests how the drug KarXT is processed in the body based on your CYP2D6 metabolism type. It helps researchers understand if different metabolizer types affect how the drug works and is cleared.
Anaheim, CaliforniaAges 18–65 - NCT07204756Recruiting
Remote blood pressure monitoring after pregnancy
This trial tests how long new mothers should monitor their blood pressure at home after delivery to find the best approach for their health. It is for people who have already joined the HOPE-BP program and are not taking blood pressure medication two weeks after birth.
Minneapolis, MinnesotaAges 18 years+ - NCT07205003Recruiting
Artery stiffness test for memory disorders
This study looks at how the stiffness of your carotid artery (the main artery in your neck) relates to memory problems. It involves a brain MRI that you may already have planned, and results could help doctors better understand certain types of dementia.
RouenAges 70 years+ - NCT07205159RecruitingPhase 1
A study of FB102 for severe alopecia areata
This trial tests a new drug called FB102 for people with severe to very severe alopecia areata, a condition that causes at least half of scalp hair to be lost. It aims to see if the drug is safe and can help hair grow back.
Saint Leonards, New South Wales (nsw)Ages 18–75 - NCT07205315RecruitingEarly Phase 1
Testing GT801 cell therapy for blood cancer and AIHA
This study tests an investigational cell therapy called GT801 for people whose CD19-positive blood cancer (B-ALL, CLL, or B-NHL) or autoimmune hemolytic anemia (AIHA) has not responded to standard treatments. The therapy is made from your own immune cells, modified to target and destroy cancer cells or abnormal immune cells.
Zhengzhou, HenanAges 18–75 - NCT07205510Recruiting
Muscle Loss, Metabolism, and Aging Study (SMILE)
This study looks at how muscle loss (sarcopenia) and metabolic problems (like diabetes or obesity) relate to aging over time. It aims to find better ways to track and treat these age-related changes.
ShanghaiAges 18 years+ - NCT07205731RecruitingPhase 2
Tislelizumab for older adults with advanced esophageal cancer
This trial tests a drug called tislelizumab (an immunotherapy) in older adults (70+) with advanced esophageal cancer who cannot have standard chemotherapy. The goal is to see if the drug can slow or shrink the cancer safely.
Annecy, Epagny Metz-TessyAges 70 years+ - NCT07205926RecruitingPhase 1
Testing a new Shigella vaccine in healthy adults
This trial tests a new Shigella vaccine in healthy adults to see if it is safe and creates a good immune response. It is a first-in-human study, meaning this is the first time the vaccine is given to people.
Cincinnati, OhioAges 18–49 - NCT07206498RecruitingPhase 1/Phase 2
Study of WSD0922-FU with Osimertinib for advanced NSCLC
This trial tests a new combination treatment (WSD0922-FU plus osimertinib) for people with advanced non-small cell lung cancer (NSCLC) that has a specific EGFR mutation. The goal is to see if the combination is safe and effective.
ShanghaiAges 18 years+ - NCT07207070RecruitingPhase 3
New drug combination for PIK3CA-mutated breast cancer
This trial tests a new combination of two drugs (JS105 plus dalpiciclib and fulvestrant) against a standard combination (dalpiciclib plus fulvestrant) for people whose breast cancer has a PIK3CA mutation. The goal is to see if adding JS105 helps control the cancer longer.
Beijing, Beijing MunicipalityAges 18–75 - NCT07207993Recruiting
AI fitness wearables for older adults with mild memory concerns
This study tests if using an AI-powered fitness wearable and app can help older adults living alone who have mild memory problems stay active. It aims to see if the technology improves health and well-being.
Knoxville, TennesseeAges 65 years+ - NCT07208591RecruitingPhase 3
Test of an experimental drug for severe viral lung infection (ARDS)
This study tests an experimental drug (STSA-1002) for people with severe breathing problems caused by a viral infection. It aims to see if the drug can help improve oxygen levels and reduce the need for a breathing machine.
Beijing, Beijing MunicipalityAges 18–85 - NCT07208669Recruiting
Treating high blood pressure in the hospital
This trial tests if treating high blood pressure in hospital patients can improve outcomes. If you are on a general medical unit and have very high blood pressure, this study may help understand the best approach.
Cleveland, OhioAges 18 years+ - NCT07208643Recruiting
Long-term stability of dental implant infection treatments
This study checks if previous treatments for peri-implantitis (infection around dental implants) stay effective after 3 years. It follows patients who already finished a prior clinical trial comparing surgical and non-surgical treatments.
Sant Cugat del Vallès, BacelonaAges Any age - NCT07208916Recruiting
Can eating grapes boost strength and thinking in older women?
This study tests whether eating grapes daily can help improve muscle strength and memory in healthy women aged 65 and older. If you join, you will need to follow a special diet that limits certain foods and supplements.
Springfield, MassachusettsAges 65 years+ - NCT07209410RecruitingPhase 4
Eye drops to reduce redness from glaucoma treatment
This trial tests if adding brimonidine eye drops can reduce eye redness caused by the glaucoma drops you are currently taking. It may help if you have been using netarsudil/latanoprost drops and have noticed redness.
Kansas City, MissouriAges 18–65 - NCT07210086RecruitingPhase 2
PET scans to guide radiation for limited metastatic prostate cancer
This trial uses a special PET scan (POSLUMA) before and after radiation to see if it helps treat prostate cancer that has spread to a few spots outside the pelvis. It's for men whose cancer still responds to hormone therapy and who have not had widespread spread.
Duarte, CaliforniaAges 18 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,340 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.